283 related articles for article (PubMed ID: 9881424)
1. Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.
O'Riordan JM; Conroy A; Nourse C; Yap PL; McDonald GS; Kaminski G; Leong K; Lawlor E; Davoren A; Strong K; Davidson F; Lloyd A; Power J
Transfus Med; 1998 Dec; 8(4):303-8. PubMed ID: 9881424
[TBL] [Abstract][Full Text] [Related]
2. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.
Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM
Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225
[TBL] [Abstract][Full Text] [Related]
3. Transfusion transmission of HCV infection before anti-HCV testing of blood donations in England: results of the national HCV lookback program.
Transfusion; 2002 Sep; 42(9):1146-53. PubMed ID: 12430671
[TBL] [Abstract][Full Text] [Related]
4. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.
Conry-Cantilena C; VanRaden M; Gibble J; Melpolder J; Shakil AO; Viladomiu L; Cheung L; DiBisceglie A; Hoofnagle J; Shih JW
N Engl J Med; 1996 Jun; 334(26):1691-6. PubMed ID: 8637513
[TBL] [Abstract][Full Text] [Related]
5. Transmission of HCV infection by RIBA indeterminate and positive blood units.
Kolho E; Naukkarinen R; Krusius T
Transfus Med; 1992 Sep; 2(3):243-8. PubMed ID: 1285012
[TBL] [Abstract][Full Text] [Related]
6. Risk of hepatitis C virus infection in multiply transfused premature neonates.
Beeby PJ; Spencer JD; Cossart YE
J Paediatr Child Health; 2001 Jun; 37(3):244-6. PubMed ID: 11468038
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence and mother-to-infant transmission of hepatitis C in asymptomatic Egyptian women.
Kumar RM; Frossad PM; Hughes PF
Eur J Obstet Gynecol Reprod Biol; 1997 Dec; 75(2):177-82. PubMed ID: 9447371
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus transmission, 1988-1991, via blood components from donors subsequently found to be anti-HCV-positive.
Foberg U; Ekermo B; Widell A; Mathiesen U; Fryden A
Scand J Infect Dis; 1996; 28(1):21-6. PubMed ID: 9122627
[TBL] [Abstract][Full Text] [Related]
9. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial.
González A; Esteban JI; Madoz P; Viladomiu L; Genesca J; Muñiz E; Enríquez J; Torras X; Hernández JM; Quer J
Hepatology; 1995 Aug; 22(2):439-45. PubMed ID: 7635410
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients.
Skaug K; Li H; Jonassen TO; Larsen J; Figenschau KJ
Vox Sang; 1993; 64(4):215-9. PubMed ID: 7685969
[TBL] [Abstract][Full Text] [Related]
12. Transmission of hepatitis C virus by transfusion in Orebro County, Sweden, 1990-1992.
Norda R; Duberg AS; Sönnerborg A; Olcén P
Scand J Infect Dis; 1995; 27(5):449-52. PubMed ID: 8588133
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.
Vogt M; Lang T; Frösner G; Klingler C; Sendl AF; Zeller A; Wiebecke B; Langer B; Meisner H; Hess J
N Engl J Med; 1999 Sep; 341(12):866-70. PubMed ID: 10498458
[TBL] [Abstract][Full Text] [Related]
14. Look-back of anti-HCV ELISA-positive, HCV-RNA PCR-negative donors and recipients of their blood products.
Vrielink H; Reésink HW; Zaaijer HL; Scholten E; Kremer LC; Cuypers HT; Lelie PN; van Oers MH; van der Poel CL
Vox Sang; 1997; 72(2):67-70. PubMed ID: 9088071
[TBL] [Abstract][Full Text] [Related]
15. Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation.
Lawlor E; Power J; Garson J; Yap P; Davidson F; Columb G; Smith D; Pomeroy L; O'Riordan J; Simmonds P; Tedder R
Vox Sang; 1999; 76(3):138-43. PubMed ID: 10341327
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C lookback programme: a single hospital experience.
Pawson R; Rajan S; Hazlehurst G; Dusheiko G; Miller R; Hewitt P; Mehta A
Transfus Med; 1999 Sep; 9(3):189-93. PubMed ID: 10555811
[TBL] [Abstract][Full Text] [Related]
17. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV.
Hitzler WE; Runkel S
Transfusion; 2001 Mar; 41(3):333-7. PubMed ID: 11274586
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C in blood transfusion recipients identified at the Oxford Blood Centre in the national HCV look-back programme.
Dike AE; Christie JM; Kurtz JB; Teo CG
Transfus Med; 1998 Jun; 8(2):87-95. PubMed ID: 9675784
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors.
Salmerón FJ; Palacios A; Pérez-Ruiz M; Torres C; Oyonarte S; Fernández-Montoya A; Ruiz-Extremera A
Dig Dis Sci; 1996 Oct; 41(10):1933-8. PubMed ID: 8888703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
